UCB - Market Capitalization

Stock Price
252.20
Daily Change
2.60 1.04%
Monthly
-11.04%
Yearly
36.36%
Q1 Forecast
243.41

UCB reported EUR47.8B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 32.44B 1.36B Mar/2026
Almirall EUR 2.66B 102.29M Mar/2026
Amarin USD 341M 4M Sep/2025
argenx SE USD 38.95B 12.88B Mar/2026
AstraZeneca USD 288.15B 55.08B Dec/2025
Bayer EUR 36.89B 535.42M Mar/2026
Galapagos EUR 1.89B 49.73M Mar/2026
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
GRIFOLS EUR 4.43B 3.06B Mar/2026
Hikma Pharmaceutical USD 2.92B 1.72B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.3B 6B Mar/2026
Novartis USD 265.66B 9.48B Sep/2025
Orion EUR 8.94B 243.74M Dec/2025
Recordati EUR 10.15B 660.84M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Unibail Rodamco EUR 11.62B 1.25B Jun/2025